Overall Survival with Durvalumab Versus Placebo After Chemoradiotherapy in Stage III NSCLC: Updated Results from PACIFIC


Creative Commons License

Antonia S., Villegas A., Daniel D., Vicente D., Murakami S., Hui R., ...Daha Fazla

JOURNAL OF THORACIC ONCOLOGY, cilt.13, sa.10, 2018 (SCI-Expanded, Scopus) identifier